Coloplast A / S – Advert no. 09/2021


Coloplast has signed an agreement to acquire Atos Medical, world leader in the laryngectomy market, for € 2,155 million (around DKK 16 billion) from PAI Partners

  • Coloplast has signed an agreement to acquire Atos Medical, the global market leader in laryngectomy from PAI Partners, a global private equity firm headquartered in Paris.

  • Closely related to Atos Medical’s goal of making life easier for people with cervical ostomies is Coloplast’s goal of making life easier for people with intimate care needs.

  • Atos Medical represents a new category of long-term growth for Coloplast, operating with its own identity, brand and execution force while leveraging Coloplast’s industry-leading capabilities and track record to drive continued growth and creation of value

  • Following the expected acquisition, Coloplast enters a new chronic care segment which will be managed as a separate strategic business unit operating on the shared Coloplast infrastructure.

  • The total purchase price (enterprise value) of Atos Medical is € 2,155 million (approx. DKK 16 billion)

Investor and analyst conference call

Coloplast will host a conference call for investors and analysts today, Monday, November 8, 2021, at 11:00 a.m. CET to discuss this announcement.
Access the webcast of the conference call directly here:

Contact details for investors and analysts who wish to actively participate in the question-and-answer session:
DK: +45 3544 5577, UK: +44 3333 000 804, USA: +1 631 913 1422
Access code: 56993966 #

For more information, please contact

Investors and analysts
Anders Lonning-Skovgaard
Executive Vice President, Chief Financial Officer
Phone. +45 4911 1111

Ellen bjurgert
Vice-President, Investor Relations
Phone. +45 4911 1800 / + 45 4911 3376
Email: [email protected]

Aleksandra Dimovska
Senior Director, Investor Relations
Phone. +45 4911 1800 / +45 4911 2458
Email: [email protected]

Press and media
Peter Münster
Senior Media Relations Officer
Phone. +45 4911 2623
Email: [email protected]

Coloplast A / S
Holtedam 1
DK-3050 Humlebaek
Reg. (CVR) no. 69749917


This announcement is available in a Danish version and an English version. In case of discrepancies, the Danish version will prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. By working closely with the people who use our products, we create solutions that are sensitive to their specific needs. We call it intimate health care. Our business includes ostomy care, incontinence care, wound and skin care, and interventional urology. We operate worldwide and employ approximately 12,500 people.

The Coloplast logo is a registered trademark of Coloplast A / S. © 2021-11.
All rights reserved Coloplast A / S, 3050 Humlebaek, Denmark.



About Author

Leave A Reply